High frequency of shared clonotypes in human B cell receptor repertoires

Cinque Soto(National Institutes of Health), James E. Crowe(Vanderbilt University Medical Center), Pranathi Matta(Vanderbilt University Medical Center), Nurgun Kose(Vanderbilt University Medical Center), Alexander M. Sevy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jessica A. Finn, Robin Bombardi(Vanderbilt University Medical Center), Andre Branchizio(Vanderbilt University Medical Center), Robert S. Sinkovits(San Diego Supercomputer Center), Pavlo Gilchuk(AstraZeneca (Japan))
Nature
February 1, 2019
10.1038/s41586-019-0934-8
Cited by 342

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543